Samsung Makes Big Play in Drug Market With Cheaper Version of Blockbuster Humira Samsung group arm is on track to win European regulatory approval for a near-replica version of the world’s top-selling drug, rheumatoid-arthritis treatment Humira, the latest achievement by the deep-pocketed South Korean conglomerate attempting to Read more ... shake up the pharmaceutical market.

Samsung, Facing Calls for a Shake-Up, Offers ‘Plan B’ Samsung Electronics surprised investors and South Korean lawmakers by saying the conglomerate would cancel some $35 billion in legacy treasury shares and forgo restructuring into a holding company.

Samsung’s Restructuring Plan Faces Challenges Samsung Electronics’ chief executive said that officials see challenges in restructuring the sprawling Samsung conglomerate, with a continuing review revealing “adverse implications” to switching to a holding-company structure.

Samsung Heir Lee Rejects Claims Company Paid Kickbacks Samsung heir apparent Lee Jae-yong rejected lawmakers’ claims that the company paid kickbacks to the government in exchange for political favors, as he faced questioning over the conglomerate’s connections with South Korean officials.

In S. Korea, Samsung's Recall Troubles Come At An Already Crucial Moment In Samsung's home country, the conglomerate was already feeling the heat in more ways than one.

Samsung Bioepis Seeks New Drug Approval The subsidiary of Samsung BioLogics, part of the Samsung Group conglomerate, has applied for European regulatory approval of its near-replica of a blockbuster breast-cancer drug. Photo: Samsung

Samsung scion to take board role at flagship amid Note 7 shock

Samsung Targets U.S. Drug Market With Remicade Knockoff Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.

Look Smart: Samsung Has Designs on Fashion South Korea’s biggest conglomerate wants to uncover the next big thing in wearable technology. The WSJ's Min-Jeong Lee examines some of the “smart” products the Samsung Group's fashion affiliate is trying on for size, including the smart belt a Read more ... nd the smart suit.

Samsung C&T Shareholders Approve $8 Billion Merger With Cheil Industries The Samsung conglomerate’s controlling Lee family scored a victory in its battle against U.S. hedge fund Elliott Associates, as shareholders approved an $8 billion merger of two Samsung affiliates.